These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36625721)

  • 1. Treatment of Langerhans cell histiocytosis with subcutaneous cytarabine.
    Eckstein OS; Bernhardt MB; Hood CG; Karri V; Kralik SF; McClain KL
    Pediatr Hematol Oncol; 2023; 40(5):497-505. PubMed ID: 36625721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-existence of Langerhans cell histiocytosis and reticulohistiocytosis with initial presentation of skull lesions: A case report.
    Shen WC; Chang Liao NF; Lin TY; Wu PY
    J Cutan Pathol; 2019 Jan; 46(1):62-66. PubMed ID: 30251332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurodegenerative central nervous system Langerhans cell histiocytosis and coincident hydrocephalus treated with vincristine/cytosine arabinoside.
    Allen CE; Flores R; Rauch R; Dauser R; Murray JC; Puccetti D; Hsu DA; Sondel P; Hetherington M; Goldman S; McClain KL
    Pediatr Blood Cancer; 2010 Mar; 54(3):416-23. PubMed ID: 19908293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recognition and treatment of concurrent active and neurodegenerative langerhans cell histiocytosis: a case report.
    Ehrhardt MJ; Karst J; Donohoue PA; Maheshwari M; McClain KL; Bingen K; Kelly ME
    J Pediatr Hematol Oncol; 2015 Jan; 37(1):e37-40. PubMed ID: 24322503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lenalidomide induced therapeutic response in a patient with aggressive multi-system Langerhans cell histiocytosis resistant to 2-chloro-deoxyadenosine and early relapsing after high-dose BEAM chemotherapy with autologous peripheral blood stem cell transplantation].
    Adam Z; Rehák Z; Koukalová R; Szturz P; Krejčí M; Pour L; Zahradová L; Moulis M; Kodet R; Nebeský T; Brejcha M; Adamová Z; Hájek R; Mayer J
    Vnitr Lek; 2012 Jan; 58(1):62-71. PubMed ID: 22448704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastrointestinal involvement in disseminated Langerhans cell histiocytosis (LCH) with durable complete response to 2-chlorodeoxyadenosine and high-dose cytarabine.
    Choi SW; Bangaru BS; Wu CD; Finlay JL
    J Pediatr Hematol Oncol; 2003 Jun; 25(6):503-6. PubMed ID: 12794533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and prognostic characteristics of 95 cases of Langerhans cell histiocytosis in children: a single-institute experience from 2013 to 2020.
    Tang X; Gao J; Ma ZG; Guo X; Li Q; Wan Z; Sun JJ
    Ann Med; 2021 Dec; 53(1):1537-1546. PubMed ID: 34459688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [MR-documented remission of pituitary stalk infiltration in patients with Langerhans cell histiocytosis following treatment with 2-chlorodeoxyadenosine].
    Vanícek J; Adam Z; Balsíková K; Krejcí M; Pour L; Szturz P; Zahradová L; Hájek R; Koukalová R; Rehák Z; Král Z; Mayer J
    Vnitr Lek; 2011 Oct; 57(10):871-5. PubMed ID: 22097697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central diabetes insipidus as a very late relapse limited to the pituitary stalk in Langerhans cell histiocytosis.
    Nakagawa S; Shinkoda Y; Hazeki D; Imamura M; Okamoto Y; Kawakami K; Kawano Y
    J Pediatr Endocrinol Metab; 2016 Jul; 29(7):873-8. PubMed ID: 27089406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensified and prolonged therapy comprising cytarabine, vincristine and prednisolone improves outcome in patients with multisystem Langerhans cell histiocytosis: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study.
    Morimoto A; Shioda Y; Imamura T; Kudo K; Kawaguchi H; Sakashita K; Yasui M; Koga Y; Kobayashi R; Ishii E; Fujimoto J; Horibe K; Bessho F; Tsunematsu Y; Imashuku S
    Int J Hematol; 2016 Jul; 104(1):99-109. PubMed ID: 27040279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of refractory Langerhans cell histiocytosis (LCH) with a combination of 2-chlorodeoxyadenosine and cytosine arabinoside.
    Apollonsky N; Lipton JM
    J Pediatr Hematol Oncol; 2009 Jan; 31(1):53-6. PubMed ID: 19125089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Langerhans Cell Histiocytosis of the Temporal Bone with Otic Capsule Involvement.
    Blumberg JM; Malhotra A; Wu X; Virk RK; Kveton JF; Michaelides EM
    Clin Neuroradiol; 2017 Jun; 27(2):163-168. PubMed ID: 26341354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term complications in uniformly treated paediatric Langerhans histiocytosis patients disclosed by 12 years of follow-up of the JLSG-96/02 studies.
    Sakamoto K; Morimoto A; Shioda Y; Imamura T; Imashuku S;
    Br J Haematol; 2021 Feb; 192(3):615-620. PubMed ID: 33236384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensification of treatment with vinca alkaloid does not improve outcomes in pediatric patients with Langerhans cell histiocytosis: results from the JPLSG LCH-12 study.
    Morimoto A; Shioda Y; Kudo K; Kanegane H; Imamura T; Koh K; Kosaka Y; Yuza Y; Nakazawa A; Saito AM; Watanabe T; Nakazawa Y
    Int J Hematol; 2023 Jul; 118(1):107-118. PubMed ID: 36871086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytosine-arabinoside, vincristine, and prednisolone in the treatment of children with disseminated Langerhans cell histiocytosis with organ dysfunction: experience at a single institution.
    Egeler RM; de Kraker J; Voûte PA
    Med Pediatr Oncol; 1993; 21(4):265-70. PubMed ID: 8469221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of children with multiple system Langerhans cell histiocytosis by Japan Langerhans Cell Histiocytosis Study Group Protocol].
    Huang JB; Xue HM; Chen YY; Huang K
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):146-9. PubMed ID: 23484709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermediate-dose cytarabine is an effective therapy for adults with non-Langerhans cell histiocytosis.
    Liu T; Cai HC; Cai H; Chen M; Zhang W; Li J; Zhou DB; Cao XX
    Orphanet J Rare Dis; 2022 Feb; 17(1):39. PubMed ID: 35130950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Langerhans Cell Histiocytosis Involving Second Cervical Vertebra and the Hypothalamus and Pituitary in an Adult.
    Yang IC; Lee GJ; Han MS; Lee SK; Moon BJ; Lee JK
    World Neurosurg; 2020 Oct; 142():142-146. PubMed ID: 32615288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Langerhans-cell histiocytosis (histiocytosis X); 20-year experience in the Emma Kinderziekenhuis, 1969-1988].
    Egeler RM; de Kraker J; Voûte PA
    Ned Tijdschr Geneeskd; 1993 May; 137(19):955-60. PubMed ID: 8497330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment outcomes and prognostic factors of patients with adult Langerhans cell histiocytosis.
    Cao XX; Duan MH; Zhao AL; Cai H; Chen J; Gao XM; Liu T; Cai HC; Zhang L; Sun J; Liang ZY; Zhou DB; Li J
    Am J Hematol; 2022 Feb; 97(2):203-208. PubMed ID: 34797941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.